tolbutamide has been researched along with thiazoles in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 7 (53.85) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Freeman, RG; Knox, JM; Murtishaw, W | 1 |
Beck, H; Vignalou, J | 1 |
de Souza, CJ; Meglasson, MD; Robinson, DD; Ulrich, RG; Yu, JH | 1 |
Emoto, M; Inoue, Y; Kaku, K; Kaneko, T; Murano, K | 1 |
Baum, ST; Bergman, RN; Elson, DF; Kemnitz, JW; Meglasson, MD; Roecker, EB | 1 |
Engelhardt, G; Homma, D; Schlegel, K; Schnitzler, C; Utzmann, R | 1 |
Azen, S; Berkowitz, K; Buchanan, TA; Dunn, ME; Goico, J; Kjos, SL; Marroquin, A; Peters, R; Xiang, A | 1 |
Boden, PR; Ibbotson, T; Lee, K; Richardson, PJ | 1 |
Boden, P; Lee, K | 1 |
Ashford, ML; Campbell, CM; Kinsella, JM; McKay, NG | 1 |
Azen, SP; Berkowitz, K; Buchanan, TA; Goico, J; Kjos, SL; Marroquin, A; Ochoa, C; Peters, RK; Xiang, AH | 1 |
Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI | 1 |
Chan, TS; Kehtani, SR; Khetani, SR; Moore, A; Tweedie, D; Yu, H | 1 |
2 trial(s) available for tolbutamide and thiazoles
Article | Year |
---|---|
Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; California; Cholesterol, HDL; Cholesterol, LDL; Chromans; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Glucose Intolerance; Glucose Tolerance Test; Hispanic or Latino; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Placebos; Pregnancy; Risk Assessment; Risk Factors; Thiazoles; Thiazolidinediones; Tolbutamide; Triglycerides; Troglitazone | 1996 |
Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.
Topics: Adult; Chromans; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Pregnancy; Risk Factors; Thiazoles; Thiazolidinediones; Tolbutamide; Troglitazone | 2000 |
11 other study(ies) available for tolbutamide and thiazoles
Article | Year |
---|---|
Tissue culture techniques in the study of cell photobiology and phototoxicity.
Topics: Animals; Antimalarials; Carcinoma; Cell Line; Coloring Agents; Coumarins; Culture Media; Culture Techniques; Fibroblasts; Haplorhini; Humans; Kidney; Laryngeal Neoplasms; Light; Methods; Penicillins; Phenothiazines; Photosensitivity Disorders; Porphyrins; Rabbits; Sulfanilamides; Tetracycline; Thiazoles; Tolbutamide | 1970 |
[A new hypoglycemic sulfonamide: AN1324].
Topics: Age Factors; Blood Glucose; Carbutamide; Chlorpropamide; Diabetes Mellitus; Humans; Hypoglycemic Agents; Sulfonamides; Thiazoles; Time Factors; Tolbutamide | 1968 |
Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance.
Topics: Aging; Amino Acids; Animals; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucose; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Pioglitazone; Rats; Rats, Zucker; Reference Values; Thiazoles; Thiazolidinediones; Tolbutamide | 1995 |
CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes.
Topics: Animals; Chromans; Cyclic AMP; Dose-Response Relationship, Drug; Fructosediphosphates; Glucagon; Liver; Male; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Tolbutamide; Troglitazone | 1994 |
Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Eating; Fasting; Feeding Behavior; Female; Glucose Tolerance Test; Heart Rate; Hypoglycemic Agents; Insulin; Insulin Resistance; Macaca mulatta; Male; Obesity; Pioglitazone; Thiazoles; Thiazolidinediones; Tolbutamide; Triglycerides | 1994 |
General pharmacology of meloxicam--Part II: Effects on blood pressure, blood flow, heart rate, ECG, respiratory minute volume and interactions with paracetamol, pirenzepine, chlorthalidone, phenprocoumon and tolbutamide.
Topics: Acetaminophen; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Blood Pressure; Cats; Chlorthalidone; Diuretics; Dogs; Drug Interactions; Electrocardiography; Guinea Pigs; Heart Rate; Hemodynamics; Hypoglycemic Agents; Meloxicam; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Phenprocoumon; Pirenzepine; Rabbits; Rats; Rats, Inbred Strains; Regional Blood Flow; Respiratory Mechanics; Thiazines; Thiazoles; Tolbutamide | 1996 |
Inhibition of KATP channel activity by troglitazone in CRI-G1 insulin-secreting cells.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Chromans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Patch-Clamp Techniques; Potassium Channel Blockers; Rats; Thiazoles; Thiazolidinediones; Tolbutamide; Troglitazone | 1996 |
Troglitazone inhibits type 2KATP channel activity and depolarises tolbutamide-sensitive neurones in the rat ventromedial hypothalamus.
Topics: Adenosine Triphosphate; Animals; Chromans; Hypoglycemic Agents; Male; Neurons; Organ Culture Techniques; Patch-Clamp Techniques; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Tolbutamide; Troglitazone; Ventromedial Hypothalamic Nucleus | 1997 |
Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Benzopyrans; Cell Line; Dose-Response Relationship, Drug; Female; Glyburide; Humans; Indoles; Membrane Potentials; Mice; Microinjections; Oocytes; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; RNA, Complementary; Sodium Azide; Sulfonylurea Receptors; Thiazoles; Thiazolidinediones; Tolbutamide; Xenopus laevis | 2000 |
Pharmacological evidence for the activation of Ca2+-activated K+ channels by meloxicam in the formalin test.
Topics: 4-Aminopyridine; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Apamin; Behavior, Animal; Charybdotoxin; Dose-Response Relationship, Drug; Female; Formaldehyde; Glyburide; Meloxicam; Pain; Pain Measurement; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Tetraethylammonium; Thiazines; Thiazoles; Tolbutamide | 2005 |
Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac.
Topics: Alprazolam; Cells, Cultured; Cryopreservation; Cytochrome P-450 Enzyme System; Hepatocytes; Humans; Liver; Meloxicam; Metabolic Clearance Rate; Thiazines; Thiazoles; Tolbutamide | 2013 |